*Correspondence: Kari Raij, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Health Canada has seized more than two dozen different types of illegal, injectable peptide drugs sold by a Calgary business this week
Most formulas deliver 250-1000 mcg per spray ours administers 625 mcg, placing it in the mid-range
OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Your doctor will determine the appropriate schedule based on your specific condition and response
documented BPC-157's protective effects against liver damage induced by diclofenac, ibuprofen, and other NSAIDs in rat models [1]